GENE ONLINE|News &
Opinion
Blog

Venture Capital
Biotech Start-ups May Face a Foreboding Prospect Following Silicon Valley Bank (SVB)’s Unsuspected Collapse
2023-03-14
Forbion Looks to Fund IPO Ambitious Companies With Its €470 Million Fund
2022-06-10
AACR 2022: Raising Capital for Drugs of the Future- Cell Therapies
2022-04-18
SeaX Ventures on $60 Million Journey to Aid Startups in Southeast Asia
2022-04-06
Alliance Formed: SV Investment and Orange Grove Bio Jointly Source and Develop Novel Medications in the U.S. and Korea
2022-03-16
Biotech Showcase 2022: The China Factor
2022-01-24
How Can Taiwan’s Biopharma Seize the Next Global Business Opportunity? – An Interview with Dr. Jerome Shen
2021-10-17
What are Investors Looking for in a Biotech Startup?
2021-07-27
Finding Strategic Partnerships: Insider Perspectives On Biopharma Deals and Market Trends
2021-06-18
Scribe Therapeutics Bags $100 Million in Series B to Advance CRISPR-Based Therapies
2021-04-01
BIOCEO21 Highlights: Criteria for Successful Launches of Biotech SPACs
2021-02-21
BIOCEO21: Scientists and Investors Weigh on Pioneering Innovations and Investments in Oncology
2021-02-18
Sana Biotechnology Makes Wall Street Debut with $587.5 Million IPO
2021-02-05
Putting the Bio in Canadian Biomanufacturing
2020-12-25
Top Highlights of BIO Asia-Taiwan 2020
2020-07-29Partner
1 2
LATEST
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
HHS Issues Initial Guidance on Negotiation Program as Government’s Latest Move to Reduce Drug Prices
2023-03-21
First-Ever Insect Brain Neuron Map Completed
2023-03-21
AbbVie Unveils Latest Data For Skyrizi In Difficult-To-Treat Psoriasis
2023-03-20
Sanofi Slashes Insulin Prices by Up to 78% Following Hot On the Heels of Major Competitors
2023-03-19
Novartis Snags Pediatric Brain Cancer Indication for Oncology Combination Therapy
2023-03-19
Pfizer, Astellas’ Prostate Cancer Drug Xtandi Achieves Goals In Phase 3
2023-03-19
Scroll to Top